Journals / Literatür Eczacılık Bilimleri Dergisi / 2021 / Cilt: 10 - Sayı: 3

Parkinson’s Disease, Genetic Factors and Endoplasmic Reticulum Stress: Systemic Review

Parkinson Hastalığı, Genetik Faktörler ve Endoplazmik Retikulum Stresi: Sistematik Derleme

Pages
343–357
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we aimed to investigate and give information about PD, ER stress, proteins involved in the ER stress pathway, unfolded protein response (UPR) and the relationship between ER stress and PD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Parkinson's disease (PD) is a progressive neurodegenerative disease affecting a significant population.
📊
Key Findings & Data:It is known that age is the most important risk factor in the development of PD and its incidence increases with age.
💡
Conclusion & Impact:In this review, we aimed to investigate and give information about PD, ER stress, proteins involved in the ER stress pathway, unfolded protein response (UPR) and the relationship between ER stress and PD.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease affecting a significant population. Since multi-factor formation mechanisms are not fully elucidated, many studies are being conducted on its pathogenesis. It is known that age is the most important risk factor in the development of PD and its incidence increases with age. Exposure to environmental pollutants such as pesticides, herbicides and heavy metals were also associated with PD. Among the genes involved in the pathogenesis, Parkin (PARK2), PTEN-induced kinase (PINK1; PARK6), PD protein 7 (DJ-1, PARK7), α-synuclein (PARK1/4) and leucine-rich repeat kinase 2 (LRRK2, PARK8) take place. Endoplasmic reticulum (ER) stress, a highly investigated subject in the last years, is associated with many diseases such as PD, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis, and obesity. It has been observed that neuronal death, oxidative stress, mitochondrial dysfunction and ER stress lead to neurodegeneration in PD. According to these studies, the level of ER stress is very important. Although it does not have potential to have a direct effect on the pathogenesis of PD, it has been observed that it prepares the environment for neurodegeneration and ensures its progression. The elucidation of ER stress on PD models and investigation of ER stress mechanisms will be of great importance in the development of new effective neuroprotective agents in treatment. In this review, we aimed to investigate and give information about PD, ER stress, proteins involved in the ER stress pathway, unfolded protein response (UPR) and the relationship between ER stress and PD.

Özet

Parkinson hastalığı (PH), popülasyonun önemli bir kısmını etkileyen, ilerleyici özellikte, nörodejeneratif bir hastalıktır. Çok faktörlü oluşum mekanizmaları tam olarak aydınlatılamadığı için patogenezi üzerinde birçok çalışma yürütülmektedir. PH gelişiminde en önemli risk faktörünün yaş olduğu ve hastalığın insidansının yaş ile arttığı bilinmektedir. Pestisitler, herbisitler ve ağır metaller gibi çevresel kirleticilere maruziyet de PH ile ilişkilendirilmiştir. Hastalığın patogenezinde rol oynayan genler arasında Parkin (PARK2), PTEN ile indüklenen kinaz (PINK1; PARK6), PH proteini 7 (DJ-1, PARK7), α-sinüklein (PARK1/4) ve lösince zengin tekrarlı kinaz 2 (LRRK2, PARK8) sayılabilir. Endoplazmik retikulum (ER) stresi; PH, Alzheimer hastalığı, Huntington hastalığı, amyotrofik lateral skleroz ve obezite gibi birçok hastalıkla ilişkilidir ve son yıllarda üzerinde en çok çalışılan konulardan biri olmuştur. PH’de nöronal ölüm, oksidatif stres ve mitokondriyal disfonksiyonla ER stresinin, nörodejenerasyona yol açtığı gözlemlenmiştir. Çalışmalara göre oluşan ER stresinin düzeyi çok önemlidir, PH patogenezinde doğrudan hastalık oluşturma potansiyeline sahip olmamakla beraber nörodejenerasyona ortam hazırladığı ve ilerlemesini sağladığı görülmüştür. ER stresinin, in vitro/in vivo şartlarda PH modelleri üzerinde aydınlatılması ve ER stresi mekanizmalarının incelenmesinin, hastalığın tedavisinde etkili yeni nöroprotektif ajanların geliştirilmesinde büyük önemi olacaktır. Bu derlemede; PH, ER stresi, ER stres yolağında görev alan proteinler, katlanmamış protein yanıtı ve ER stresi ile PH arasındaki ilişkinin incelenmesi amaçlanmıştır.

🔖

Cite This Article

YİRÜN, A., ERKEKOĞLU, P., KÖSE, S. B. E., ADALI, A. (2022). Parkinson’s Disease, Genetic Factors and Endoplasmic Reticulum Stress: Systemic Review. Literatür Eczacılık Bilimleri Dergisi, Cilt: 10 - Sayı: 3, 343–357. https://ajindex.com/articles/577573

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Mercado g, Valdés P, hetz C. an ERcentric view of Parkinson's disease. Trends Mol Med. 2013;19(3):165-75. 2. zeng Xs, geng Ws, jia jj, Chen L, zhang PP. Cellular and molecular basis of neurodegeneration in Parkinson disease. front aging Neurosci. 2018;10:109
  2. DeMaagd g, Philip a. Parkinson's disease and its management: Part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T. 2015;40(8):504-32
  3. Omura T, Kaneko M, Okuma Y, Matsubara K, Nomura Y. Endoplasmic reticulum stress and Parkinson's disease: the role of hRD1 in averting apoptosis in neurodegenerative disease. Oxid Med Cell Longev. 2013;2013: 239854
  4. Roussel BD, Kruppa aj, Miranda E, Crowther DC, Lomas Da, Marciniak sj. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 2013;12(1):105-18
  5. Kalia LV, Lang aE. Parkinson's disease. Lancet. 2015;386(9996):896-912
  6. Calì T, Ottolini D, Brini M. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease. Biofactors. 2011;37(3): 228-40
  7. Türk Nöroloji Derneği [internet]. Copyright © 2020 Türk Nöroloji Derneği [Erişim tarihi: 14.9.2020]. Dünya Beyin günü basın bülteni. Erişim linki: 9. jankovic j. Levodopa strengths and weaknesses. Neurology. 2002;58(4 suppl 1):s19- 32
  8. Connolly Bs, Lang aE. Pharmacological treatment of Parkinson disease: a review. jaMa. 2014;311(16):1670-83
  9. Quik M. smoking, nicotine and Parkinson's disease. Trends Neurosci. 2004;27(9):561-8
  10. Ross gW, abbott RD, Petrovitch h, Morens DM, grandinetti a, Tung Kh, et al. association of coffee and caffeine intake with the risk of Parkinson disease. jaMa. 2000;283(20): 2674-9. 13. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5(6):525-35
  11. Langston jW, Ballard P, Tetrud jW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. science. 1983;219(4587):979-80
  12. Lai BC, Marion sa, Teschke K, Tsui jK. Occupational and environmental risk factors for Parkinson's disease. Parkinsonism Relat Disord. 2002;8(5):297-309
  13. Polymeropoulos Mh, Lavedan C, Leroy E, Ide sE, Dehejia a, Dutra a, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. science. 1997;276 (5321):2045-7. 17. heman-ackah sM, Manzano R, hoozemans jjM, scheper W, flynn R, haerty W, et al. alpha-synuclein induces the unfolded protein response in Parkinson's disease sNCa triplication iPsC-derived neurons. hum Mol gene